Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

Completed · Phase 1

Conditions studied: Hepatic Impairment

In brief

This study will compare the pharmacokinetics of LCQ908 in subjects with varying degrees of hepatic impairment to healthy subjects.

Key facts

Study ID
NCT01594957
Run by
Novartis Pharmaceuticals
People needed
53
Starts
2012-04-01
Expected to finish
2013-04-01
Last updated by the study team
2020-12-19

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.